Correlation Between OSE Pharma and Quantum Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OSE Pharma and Quantum Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OSE Pharma and Quantum Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OSE Pharma SA and Quantum Genomics SA, you can compare the effects of market volatilities on OSE Pharma and Quantum Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OSE Pharma with a short position of Quantum Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OSE Pharma and Quantum Genomics.

Diversification Opportunities for OSE Pharma and Quantum Genomics

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between OSE and Quantum is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding OSE Pharma SA and Quantum Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Genomics and OSE Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OSE Pharma SA are associated (or correlated) with Quantum Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Genomics has no effect on the direction of OSE Pharma i.e., OSE Pharma and Quantum Genomics go up and down completely randomly.

Pair Corralation between OSE Pharma and Quantum Genomics

Assuming the 90 days trading horizon OSE Pharma is expected to generate 13.46 times less return on investment than Quantum Genomics. But when comparing it to its historical volatility, OSE Pharma SA is 9.37 times less risky than Quantum Genomics. It trades about 0.1 of its potential returns per unit of risk. Quantum Genomics SA is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2.70  in Quantum Genomics SA on August 26, 2024 and sell it today you would earn a total of  4.51  from holding Quantum Genomics SA or generate 167.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

OSE Pharma SA  vs.  Quantum Genomics SA

 Performance 
       Timeline  
OSE Pharma SA 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OSE Pharma SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, OSE Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Quantum Genomics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

OSE Pharma and Quantum Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OSE Pharma and Quantum Genomics

The main advantage of trading using opposite OSE Pharma and Quantum Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OSE Pharma position performs unexpectedly, Quantum Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Genomics will offset losses from the drop in Quantum Genomics' long position.
The idea behind OSE Pharma SA and Quantum Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites